Scientists hunt for hidden clues in blood and skin to unlock future CMT treatments
NCT ID NCT06794489
Summary
This study aims to better understand how Charcot-Marie-Tooth disease type 1A (CMT1A) progresses over time and to find biological markers that can track it. Researchers will follow 75 patients and 25 healthy volunteers for five years, collecting blood and skin samples to identify these markers. The goal is to create better tools for future clinical trials testing new CMT treatments, which are hard to evaluate due to the disease's slow progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT1A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre
RECRUITINGGöttingen, Lower Saxony, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.